Pastan; Ira

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pastan; Ira.The latest application filed is for "methods of treating pediatric acute lymphoblastic leukemia with an anti-cd22 immunotoxin".

Company Profile

0.52.19

Pastan; Ira - Potomac MD US
Pastan; Ira - Bethesda MD US
Pastan; Ira - Potamac MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors Grant 9,592,304 - FitzGerald , et al. March 14, 2	2017-03-14
Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin App 20150218286 - WAYNE; Alan S. ; et al.	2015-08-06
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells Grant 8,809,502 - Pastan , et al. August 19, 2	2014-08-19
Immunogenic epitopes of NGEP antigen Grant 8,748,390 - Schlom , et al. June 10, 2	2014-06-10
Blocking mesothelin peptide fragments Grant 8,623,828 - Ho , et al. January 7, 2	2014-01-07
Anti-mesothelin antibodies Grant 8,460,660 - Ho , et al. June 11, 2	2013-06-11
Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin App 20120177567 - WAYNE; Alan S. ; et al.	2012-07-12
Anti-mesothelin Antibodies App 20120107933 - Ho; Mitchell ; et al.	2012-05-03
Immunogenic Epitopes Of Ngep Antigen App 20120052116 - Schlom; Jeffrey ; et al.	2012-03-01
Immunogenic peptides for the treatment of prostate and breast cancer Grant 8,043,623 - Berzofsky , et al. October 25, 2	2011-10-25
Blocking Mesothelin Peptide Fragments App 20110236385 - Ho; Mitchell ; et al.	2011-09-29
IRTA2 antibodies and methods of use Grant 7,999,077 - Pastan , et al. August 16, 2	2011-08-16
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells Grant 7,777,019 - Pastan , et al. August 17, 2	2010-08-17
Recombinant Antibodies And Immunoconjugates Targeted To Cd-22 Bearing Cells And Tumors App 20090305411 - FitzGerald; David J. ; et al.	2009-12-10
Gene Expressed In Prostate Cancer And Methods Of Use App 20090304702 - Pastan; Ira ; et al.	2009-12-10
Mesothelin, A Differentiation Antigen Present On Mesothelium, Mesotheliomas, and Ovarian Cancers and Methods and Kits for Targeting the Antigen App 20090280556 - Pastan; Ira ; et al.	2009-11-12
Immunogenic Peptides For The Treatment Of Prostate And Breast Cancer App 20090208518 - Berzofsky; Jay A. ; et al.	2009-08-20
Gene expressed in prostate cancer, methods and use thereof Grant 7,572,887 - Pastan , et al. August 11, 2	2009-08-11
Immunogenic peptides for the treatment of prostate and breast cancer Grant 7,541,035 - Berzofsky , et al. June 2, 2	2009-06-02
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors Grant 7,541,034 - Fitzgerald , et al. June 2, 2	2009-06-02
Irta2 Antibodies and Methods of Use App 20080292632 - Pastan; Ira ; et al.	2008-11-27
Lambda phage display system and the process Grant 7,410,801 - Chaudhary , et al. August 12, 2	2008-08-12
Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor Grant 7,399,827 - Pastan , et al. July 15, 2	2008-07-15
Mesothelin, immunogenic peptides derived therefrom, and compositions comprising mesothelin, or immunogenic peptides thereof Grant 7,375,183 - Pastan , et al. May 20, 2	2008-05-20
Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof Grant 7,129,332 - Pastan , et al. October 31, 2	2006-10-31
Gene expressed in prostate cancer, methods and use thereof App 20060194204 - Pastan; Ira ; et al.	2006-08-31
Anti-mesothelin antibodies having high binding affinity Grant 7,081,518 - Pastan , et al. July 25, 2	2006-07-25
Immunogenic peptides for the treatment of prostate and breast cancer App 20060140967 - Berzofsky; Jay A. ; et al.	2006-06-29
T-cell receptor.gamma. alternate reading frame protein, (TARP) and uses thereof Grant 7,052,703 - Pastan , et al. May 30, 2	2006-05-30
Pharmaceutical composition for treatment of drug dependence App 20060058336 - Nakanishi; Shigetada ; et al.	2006-03-16
Recombinant immunotoxin and use in treating tumors App 20060051359 - Pastan; Ira ; et al.	2006-03-09
Novel lambda phage display system and the process App 20050181494 - Chaudhary, Vijay Kumar ; et al.	2005-08-18
Xage-1, a gene expressed in multiple cancers, and uses thereof App 20040087772 - Pastan, Ira ; et al.	2004-05-06
Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates App 20040018203 - Pastan, Ira ; et al.	2004-01-29
Anti-egfrvIII scfvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof App 20030211097 - Pastan, Ira ; et al.	2003-11-13
IL-13 receptor specific chimeric proteins & uses thereof App 20030129132 - Puri, Raj K. ; et al.	2003-07-10
IL-13 receptor specific chimeric proteins and uses thereof Grant 6,518,061 - Puri , et al. February 11, 2	2003-02-11
Protease-activatable pseudomonas exotoxin A-like proproteins Grant 6,426,075 - Fitzgerald , et al. July 30, 2	2002-07-30
Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteins Grant 6,423,513 - Fitzgerald , et al. July 23, 2	2002-07-23
Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers Grant 6,153,430 - Pastan , et al. November 28, 2	2000-11-28
Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin Grant 6,099,842 - Pastan , et al. August 8, 2	2000-08-08
Mesothelium antigen and methods and kits for targeting it Grant 6,083,502 - Pastan , et al. July 4, 2	2000-07-04
Nucleic acids encoding immunotoxins containing a disulfide-stabilized antibody fragment replacing half or more of domain IB of pseudomonas exotoxin, and methods of use of the encoded immunotoxins Grant 6,074,644 - Pastan , et al. June 13, 2	2000-06-13
Circularly permuted ligands and circularly permuted chimeric molecules Grant 6,011,002 - Pastan , et al. January 4, 2	2000-01-04
Single chain B3 antibody fusion proteins and their uses Grant 5,990,296 - Pastan , et al. November 23, 1	1999-11-23
Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation Grant 5,980,895 - Pastan , et al. November 9, 1	1999-11-09
Methods of inducing multidrug resistance using human MDR1 cDNA Grant 5,928,637 - Gottesman , et al. July 27, 1	1999-07-27
IL-13 receptor specific chimeric proteins Grant 5,919,456 - Puri , et al. July 6, 1	1999-07-06
Humanized B3 antibody fragments, fusion proteins, and uses thereof Grant 5,889,157 - Pastan , et al. March 30, 1	1999-03-30
Vectors carrying MDR1 cDNA which confer multidrug resistance on transduced cells Grant 5,851,819 - Gottesman , et al. December 22, 1	1998-12-22
Transgenic animals expressing a multidrug resistance cDNA Grant 5,849,998 - Gottesman , et al. December 15, 1	1998-12-15
Monoclonal antibodies and conjugates thereof useful for the treatment of cancer Grant 5,817,313 - Willingham , et al. October 6, 1	1998-10-06
Cellular apoptosis susceptibility protein (CSP) and antisense CSP Grant 5,759,782 - Pastan , et al. June 2, 1	1998-06-02
Target-specific, cytotoxic, recombinant pseudomonas exotoxin Grant 5,705,163 - Pastan , et al. January 6, 1	1998-01-06
IL-13 receptor specific chimeric proteins and uses thereof Grant 5,614,191 - Puri , et al. March 25, 1	1997-03-25
Single chain B3 antibody fusion proteins and their uses Grant 5,608,039 - Pastan , et al. March 4, 1	1997-03-04
Cytotoxic agent against specific virus infection Grant 5,587,455 - Berger , et al. December 24, 1	1996-12-24
Monoclonal antibody binding cell surface antigens for diagnosing cancer Grant 5,525,337 - Willingham , et al. June 11, 1	1996-06-11
Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids Grant 5,512,658 - Pastan , et al. April 30, 1	1996-04-30
Monoclonal antibody useful for the diagnosis of cancer Grant 5,320,956 - Willingham , et al. June 14, 1	1994-06-14
Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors Grant 5,242,813 - Pastan , et al. September 7, 1	1993-09-07
CD-4/cytotoxic gene fusions Grant 5,206,353 - Berger , et al. April 27, 1	1993-04-27
Gene therapy using gene fusions for genetic or acquired disorders Grant 5,166,059 - Pastan , et al. November 24, 1	1992-11-24
Selectively cytotoxic IL-4-PE40 fusion protein Grant 5,082,927 - Pastan , et al. January 21, 1	1992-01-21
Monoclonal antibody against ovarian cancer cells (OVB-3) Grant 4,806,494 - Pastan , et al. February 21, 1	1989-02-21
Pseudomonas exotoxin conjugate immunotoxins Grant 4,545,985 - Pastan , et al. October 8, 1	1985-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.